Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026)

Ginkgo Bioworks Holdings (DNA) reported Assets Average of $1.1 billion for Q1 2026, down 19.4% on a YoY basis from $1.3 billion in Q1 2025, and down 6.76% quarter-over-quarter from $1.2 billion in Q4 2025.

Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings has reported Assets Average for 6 years, with the latest figure at $1.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, Assets Average fell 19.4% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 19.4% YoY), and the FY2025 full-year result was $1.2 billion, down 17.93% from the prior year.
  • Assets Average for Q1 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
  • The five-year high for Assets Average was $2.5 billion in Q1 2023, with the low at $1.1 billion in Q1 2026.
  • Historically, Assets Average has averaged $1.7 billion across 5 years, with a median of $1.6 billion in 2024.
  • Annual changes were most pronounced in 2022 — Assets Average surged 71.8% — and 2024, when it tumbled 34.49%.
  • Ginkgo Bioworks Holdings' Assets Average stood at $2.2 billion in 2022, then retreated by 16.29% to $1.8 billion in 2023, then declined by 22.57% to $1.4 billion in 2024, then slipped by 19.22% to $1.2 billion in 2025, then decreased by 6.76% to $1.1 billion in 2026.
  • The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 33.42 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13.04 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.72 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 26.03 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 40.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.06 Bn
9 Abivax 91.96 Bn 91.96 Bn - 660.38 Mn
10 Ginkgo Bioworks Holdings 546.79 Mn 546.79 Mn 16.38 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.15 Bn
Sep 30, 2025 1.21 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.34 Bn
Dec 31, 2024 1.43 Bn
Sep 30, 2024 1.55 Bn
Jun 30, 2024 1.60 Bn
Mar 31, 2024 1.62 Bn
Dec 31, 2023 1.85 Bn
Sep 30, 2023 2.16 Bn
Jun 30, 2023 2.35 Bn
Mar 31, 2023 2.48 Bn
Dec 31, 2022 2.21 Bn
Sep 30, 2022 1.93 Bn
Jun 30, 2022 2.03 Bn
Mar 31, 2022 2.06 Bn
Dec 31, 2021 2.11 Bn
Sep 30, 2021 1.94 Bn
Jun 30, 2021 1.73 Bn